Renba Liang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, National Cancer Center, National Clinical Research · ORCID：0000-0001-5050-8847

发表论文 31 篇 · 总被引 567 次 · h-index 11

代表论文

• Anti-EGFR therapies in nasopharyngeal carcinoma (2020 · Biomedicine & Pharmacotherapy · 被引 76)
• Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma (2021 · Cancer Control · 被引 44)
• Deciphering the Roles of IFITM1 in Tumors (2020 · Molecular Diagnosis & Therapy · 被引 39)
• VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway (2020 · Scientific Reports · 被引 32)
• Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis (2021 · Frontiers in Oncology · 被引 18)
• CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R (2020 · Life Sciences · 被引 15)